RMD and RMD:AU Related Headlines
Go Back- CLSA Reiterates Outperform (2) Rating on ResMed (RMD:AU) (RMD)
- ResMed (RMD:AU) (RMD) PT Lowered to AUD48 at Citi
- ResMed (RMD:AU) (RMD) PT Lowered to AUD38.50 at CLSA
- JPMorgan Starts ResMed (RMD:AU) (RMD) at Overweight
- ResMed (RMD:AU) (RMD) PT Lowered to AUD45.25 at CLSA
- ResMed (RMD:AU) (RMD) PT Raised to AUD51 at Citi
- CLSA Upgrades ResMed (RMD:AU) (RMD) to Outperform (2)
- ResMed (RMD:AU) (RMD) PT Raised to AUD48 at JPMorgan
- CLSA Downgrades ResMed (RMD:AU) (RMD) to Hold (3)
- ResMed (RMD:AU) (RMD) PT Raised to AUD44.50 at CLSA
- RBC Capital Upgrades ResMed (RMD:AU) (RMD) to Outperform

